InvestorsHub Logo
Followers 219
Posts 16135
Boards Moderated 6
Alias Born 06/02/2007

Re: makingbiigdough post# 3167

Tuesday, 09/16/2008 11:56:07 AM

Tuesday, September 16, 2008 11:56:07 AM

Post# of 8204
"We ALL got it! YES financing sucks! Sooner it gets resolved the better! WE GOT IT!!! Sheeeeesh! MBD"

If that's the case, why do you continue to insist that Biophan is a screaming buy without posting a single specific reason why that should be?

We have heard, albeit from extremely unreliable sources, that BIPH are part way to getting approval to issue another 625 million shares on top of the current float specifically in order to feed the "sewer rat". We know that Myotech CSS remains, as ever, 24-36 months from introduction, and we have had no news on human studies for this device.

The fnancing in place was put there when Mr. Lanzafame was a Director and Weiner was CEO. You and he can't pretend he was nothing to do with it. And they have done nothing to resolve it - quite the contrary.

So why would anyone want to invest in BIPH?

(Trading for those with an exquisite sense of timing and more than their fair share of luck is a different matter, as I've always said. Just don't be surprised when you get stuck with a bunch of shares you have to offload at a loss or are literally worthless. It will happen.)

As for reading the future of this stock in the charts, anyone who has studied the empirical base for these things knows that the evidence in favor of the accuracy of charting is equivocal (at best)for larger more liquid stocks.

It's beyond doubt that charts are irrelevant for penny stocks with no commercial operations.

The major use for charts, as far as I can see, is that they provide a flimsy justification for mo-mo traders to pump penny stocks on MBs such as this one.